CT
Capricor Therapeutics Inc
🇩🇪XFRA.4LN2GermanyHealthcare
€7.50EURdown -0.05 (-0.66%)OpenEnd of day5:03 PM
Price€7.50-0.05 (-0.66%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US14070B3096
- CUSIP
- Not reported
Company
- Employees
- 231
- Headquarters
- San Diego, United States
- Website
- https://www.capricor.com
- CEO
- Dr. Linda Marbán Ph.D.
Market
- Shares outstanding
- 58.1M
- Market cap
- €436.04M
Key dates
- Next earnings
- Nov 10, 2026
Highlights
- Market cap
- €436.04M
- EPS LTM
- -$2.23
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$129.42M-84.94%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$129.78M-130.19%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.